Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

高剂量化疗和异性免疫疗法.

Richard Childs1, Ramaprasad Srinivasan

  • 1Hematology Branch, National Institutes of Health, Bethesda, MD 20892, USA. childsr@nih.gov

Lancet (London, England)
|July 26, 2005
PubMed
概括

No abstract available in PubMed .

相关实验视频

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Belzutifan efficacy in von Hippel-Lindau disease-associated renal cell carcinoma versus natural history control arm.

Journal of the National Cancer Institute·2026
Same author

Unclear territory: navigating metastatic nonclear cell renal cell carcinoma.

Current opinion in oncology·2026
Same author

Multigenerational VHL family characterized by pathogenic germline ELOC variant: Response to belzutifan.

Urologic oncology·2025
Same author

Reply to Changhong Xu, Hanxue Zheng, Yun Deng, and Li Yang's Letter to the Editor re: W. Marston Linehan, Cathy Anne Pinto, Yangang Liu, et al. Longitudinal Evaluation of Clear-cell Renal cell Carcinoma in von Hippel-Lindau Disease. Eur Urol 2025:88:56-63.

European urology·2025
Same author

Metastasectomy outcomes in renal cell carcinoma: insights from hereditary leiomyomatosis and succinate dehydrogenase deficient cohorts.

Urologic oncology·2025
Same author

Renal surgery following HIF-2α antagonist therapy: Surgical indications, outcomes and growth kinetics.

Urologic oncology·2025